Profound Medical Corp

PROFNASDAQ · USD
6.03USD+0.20 (+3.44%)
149

Profound Medical Corp (PROF) Covered Calls

As of September 16, 2026, PROF has 1 covered call opportunities in the coming three months. Return ranges from 32.9 to 32.9% until expiration. Annualized return ranges from 56.4 to 56.4%. The nearest expiration is April 16, 2027. Maximum potential profit is $187.

Read more

Running PROF covered calls helps you generate consistent income from Profound Medical Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Profound Medical Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PROF covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PROF stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PROF covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Profound Medical Corp covered call is worth writing.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain relief associated with metastases in bone, as well as non-invasive treatment of uterine fibroids.

Profound Medical Corp. is headquartered in Mississauga, Canada.

Income-focused investors, long-term PROF holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PROF covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Profound Medical Corp covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile32.14% Subdued
  • Market cap (M$)213
  • 52 weeks high-34.86%
  • 52 weeks low49.49%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$11.28
    87.06% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-12
  • P/E
  • Future P/E
  • EPS (ttm)-0.99
  • EPS growth next 5 years63.25%

As of September 16, 2026

2027-04-162137.5032.040.051.65187.0032.9256.42-0.88+0.4501.60

As of September 16, 2026

Sell covered calls with the data behind you

Find the best PROF covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial